These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13626144)

  • 21. Vi serology in screening of typhoid carriers: improved specificity by detection of Vi antibodies by counterimmunoelectrophoresis.
    Chau PY; Tsang RS
    J Hyg (Lond); 1982 Oct; 89(2):261-7. PubMed ID: 7130702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Titration of O and Vi antibodies by passive hemagglutination and Coombs' test in the blood of patients with typhoid fever].
    Păscariu C; Bîlcea M; Feticu M; Lupaş A
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(6):543-8. PubMed ID: 5378450
    [No Abstract]   [Full Text] [Related]  

  • 23. Investigation into the existence of functionally deficient Vi antibody. I. An analysis of the protective effects of S. typhi O and Vi antibodies on intraperitoneal typhoid infection of mice.
    SPAUN J; BENTZON MW
    Acta Pathol Microbiol Scand; 1957; 41(4):327-41. PubMed ID: 13469411
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of Vi-antibody formation in typhoid fever and chronic typhoid fever bacterial carriers].
    Karmanov MI
    Sov Med; 1973 May; 36(5):149-50. PubMed ID: 4768336
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
    GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
    J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bactericidal action of typhoid antibody.
    NAGINGTON J
    Br J Exp Pathol; 1956 Aug; 37(4):385-96. PubMed ID: 13364149
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the antibody in the blood sera of immune individuals with TAB vaccine.
    NAGAKI D; ANZAI H; IWASAKI K; TAKAMATSU K; UCHIYAMA T
    Kitasato Arch Exp Med; 1952 Oct; 25(2):69-82. PubMed ID: 13097701
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.
    LANDY M; GAINES S; SEAL JR; WHITSIDE JE
    Am J Public Health Nations Health; 1954 Dec; 44(12):1572-9. PubMed ID: 13207484
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contributions to the study of incomplete antibodies in typhoid fever treated with chloramphenicol].
    Gavrilă I; Turcaş-Păscariu C
    Microbiol Parazitol Epidemiol (Bucur); 1967; 12(4):315-20. PubMed ID: 5595152
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of ACTH on humoral immunity in typhoid fever; clinical experimental research].
    COLUCCI CF
    Prog Med (Napoli); 1954 Oct; 10(20):613-8. PubMed ID: 13224756
    [No Abstract]   [Full Text] [Related]  

  • 32. A simple adherence test for detection of IgM antibodies in typhoid.
    Ong LY; Pang T; Lim SH; Tan EL; Puthucheary SD
    J Med Microbiol; 1989 Jul; 29(3):195-8. PubMed ID: 2473209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple bactericidal antibody test for sero-diagnosis of typhoid fever.
    Gupta AK; Rao KM
    J Immunol Methods; 1981; 42(1):121-5. PubMed ID: 7240754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior of the opsonic power in typhoid fever treated with cortisone and chloramphenicol].
    COPAITICH T; D'AGOSTINO S
    Rass Clin Ter; 1956; 55(1):54-8. PubMed ID: 13336353
    [No Abstract]   [Full Text] [Related]  

  • 35. [Behavior of anti-Vi antibodies during typhoid fever].
    GOSCICKI J; KUKULSKA T; STEMPIEN R
    Przegl Epidemiol; 1956; 10(4):325-32. PubMed ID: 13420219
    [No Abstract]   [Full Text] [Related]  

  • 36. [Formation of antibodies of different classes in salmonelloses and typhoid fever].
    Tendetnik IuIa; Ovcharova NM; Iushchuk ND; Vetlugina KF
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):64-9. PubMed ID: 919923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunogenic power of the glucidolipidic endotoxin of S. typhi (O and Vi) emulsified in mineral oil; active immunization of the mouse towards experimental infection; O and Vi antibodies and protective power of the serum in man].
    D'ALESSANDRO G; COMES R; GULLOTTI A
    Riv Ist Sieroter Ital; 1954; 29(4):371-80. PubMed ID: 13216074
    [No Abstract]   [Full Text] [Related]  

  • 38. The formation of macroglobulin antibodies. I. Studies on adult humans.
    LOSPALLUTO J; MILLER W; DORWARD B; FINK CW
    J Clin Invest; 1962 Jul; 41(7):1415-21. PubMed ID: 14466770
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
    Yang HH; Wu CG; Xie GZ; Gu QW; Wang BR; Wang LY; Wang HF; Ding ZS; Yang Y; Tan WS; Wang WY; Wang XC; Qin M; Wang JH; Tang HA; Jiang XM; Li YH; Wang ML; Zhang SL; Li GL
    Bull World Health Organ; 2001; 79(7):625-31. PubMed ID: 11477965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of anti O, anti H, and anti Vi antibodies in phagocytic reaction].
    SKURSKI A; JARMOC Z
    Med Dosw Mikrobiol; 1953; 5(3):356-7. PubMed ID: 13132461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.